APPY1 utilizes a multi biomarker test configuration with improved performance that has been validated in more than 500 patients through a successful pilot study.
Focused on laying a solid foundation with the expectation that 2014 maybe breakout year in terms of commercial activities
News 
Market Data 
Discover 
